Affordable Access

deepdyve-link deepdyve-link
Publisher Website

MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure.

Authors
Type
Published Article
Journal
Leukemia
1476-5551
Publisher
Nature Publishing Group
Publication Date
Volume
28
Issue
7
Pages
1478–1485
Identifiers
DOI: 10.1038/leu.2014.6
PMID: 24472814
Source
Medline

Abstract

Statistics

Seen <100 times